spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Baxa 

 HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2022
Halozyme Commences Tender Offer for All Outstanding Shares of Common Stock of Antares Pharma
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2022
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2021
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 8 Apr 2021
Imvax Appoints Sean Hemingway as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 6 Oct 2020
Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Dec 2019
Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Nov 2019
Halozyme Announces Actions To Focus Strategy On ENHANZE(R) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Reduction in Force
 HSMN NewsFeed - 19 Jul 2019
Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX(R) Utilizing ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery Regulatory
 HSMN NewsFeed - 22 May 2019
Halozyme Announces argenx Has Selected Second Target Under ENHANZE(R) Technology Collaboration And License Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 May 2019
Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Feb 2019
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2019
argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE(R) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 5 Dec 2018
EUSA Pharma Appoints Jeffrey S. Hackman as President US Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Nov 2018
Hill-Rom Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 17 Sep 2018
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Sep 2018
Halozyme Appoints Bernadette Connaughton To Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 19 Mar 2018
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 4 Dec 2017
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2017
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jun 2017
Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 May 2017
Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Mar 2017
Shire Receives European Approval for Label Extension of CINRYZE(R) (C1 inhibitor ) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Nov 2016
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Oct 2016
Shire Granted EU Marketing Authorization of Onivyde(R), in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the Treatment of Metastatic Adenocarcinoma of the Pancreas in Adult Patients Who Have Progressed Following Gemcitabine-Based Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Oct 2016
OncoResponse Secures $7M in Supplemental Series A Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2016
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jul 2016
David Meek appointed as Chief Executive Officer of Ipsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2016
Shire Receives Extension of Market Authorization in Europe for Revestive(R) (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jul 2016
SI-BONE, Inc. Appoints Tony Recupero Chief Commercial Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 6 May 2016
venBio Closes $315 Million Life Sciences Venture Capital Fund
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Sep 2015
TranS1 Announces New Vice President of Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 9 Jul 2015
Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2015
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Sep 2014
Baxano Surgical to Explore Strategic Alternatives for Its MIS Spine Business
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 14 Aug 2014
Aurora Spine Appoints Regional Vice President of Sales
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 30 Jun 2014
Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 10 Apr 2014
Baxano Surgical Receives 510(k) Clearance for the Avance MIS Pedicle Screw System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 20 Mar 2014
NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE(TM) Imaging System
Devices Venture Capital
 HSMN NewsFeed - 3 Jul 2013
Baxano Surgical, Inc. Announces Definitive Settlement With Office of Inspector General
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Mar 2013
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment
Devices Neurosurgery Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2012
Baxano's iO-Tome(TM) Device Receives FDA Clearance
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 10 Nov 2011
Baxter Completes Acquisition of Baxa Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2011
Baxter to Acquire Privately Held Baxa Corporation
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 15 Feb 2011
Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 22 Jun 2010
Baxano, Inc. Announces Close of $30 Million Series C Funding
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 27 Feb 2009
Hospitals, Healthcare Providers to Save with New Premier Agreements for Feeding Pumps, Sets, Devices and Tubing
Devices Group Purchasing
 HSMN NewsFeed - 10 Nov 2008
Baxano, Inc. Names Tony Recupero as Executive Vice President, Sales and Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 14 Oct 2008
Baxa Ltd Launches ZR(R) Pre-Filled Saline Flush Syringes
Devices
 HSMN NewsFeed - 3 Dec 2007
Baxa Corporation Launches MedBoard(TM) Medication Tracking System
Devices
 HSMN NewsFeed - 3 Dec 2007
Baxa Corporation Launches Repeater(TM) Pump II With P2(TM) Technology
Devices
 HSMN NewsFeed - 10 Oct 2007
Baxa Corporation Launches PadLock(TM) Set Saver for IV Safety
Devices
 HSMN NewsFeed - 30 Apr 2007
Baxa Corporation Announces Enteral Syringes Now on Contract With AmeriNet, MedAssets, Novation and Premier Group Purchasing Organizations
Devices Group Purchasing
 HSMN NewsFeed - 18 Jan 2007
Baxa Corporation Signs Co-Marketing Agreement with VIASYS MedSystems for Specialty Enteral Feeding Products
Devices
 HSMN NewsFeed - 31 Oct 2006
Baxa Releases New 2 mL Exacta-Med(R) Dispenser for Oral Medication Delivery
Devices Drug Delivery
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Baxa
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!